• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在具有扩展的聚谷氨酰胺-EGFP荧光聚集体的亨廷顿病转基因小鼠中,下丘脑神经肽表达降低。

Decreased expression of hypothalamic neuropeptides in Huntington disease transgenic mice with expanded polyglutamine-EGFP fluorescent aggregates.

作者信息

Kotliarova Svetlana, Jana Nihar R, Sakamoto Naoaki, Kurosawa Masaru, Miyazaki Haruko, Nekooki Munenori, Doi Hiroshi, Machida Yoko, Wong Hon Kit, Suzuki Taishi, Uchikawa Chiharu, Kotliarov Yuri, Uchida Kazuyo, Nagao Yoshiro, Nagaoka Utako, Tamaoka Akira, Oyanagi Kiyomitsu, Oyama Fumitaka, Nukina Nobuyuki

机构信息

Laboratory for Structural Neuropathology, RIKEN Brain Science Institute, Wako-shi, Saitama, Japan.

出版信息

J Neurochem. 2005 May;93(3):641-53. doi: 10.1111/j.1471-4159.2005.03035.x.

DOI:10.1111/j.1471-4159.2005.03035.x
PMID:15836623
Abstract

Huntington disease is caused by polyglutamine (polyQ) expansion in huntingtin. Selective and progressive neuronal loss is observed in the striatum and cerebral cortex in Huntington disease. We have addressed whether expanded polyQ aggregates appear in regions of the brain apart from the striatum and cortex and whether there is a correlation between expanded polyQ aggregate formation and dysregulated transcription. We generated transgenic mouse lines expressing mutant truncated N-terminal huntingtin (expanded polyQ) fused with enhanced green fluorescent protein (EGFP) and carried out a high-density oligonucleotide array analysis using mRNA extracted from the cerebrum, followed by TaqMan RT-PCR and in situ hybridization. The transgenic mice formed expanded polyQ-EGFP fluorescent aggregates and this system allowed us to directly visualize expanded polyQ aggregates in various regions of the brain without performing immunohistochemical studies. We show here that polyQ-EGFP aggregates were intense in the hypothalamus, where the expression of six hypothalamic neuropeptide mRNAs, such as oxytocin, vasopressin and cocaine-amphetamine-regulated transcript, was down-regulated in the transgenic mouse brain without observing a significant loss of hypothalamic neurons. These results indicate that the hypothalamus is susceptible to aggregate formation in these mice and this may result in the down-regulation of specific genes in this region of the brain.

摘要

亨廷顿舞蹈症是由亨廷顿蛋白中的多聚谷氨酰胺(polyQ)扩增引起的。在亨廷顿舞蹈症患者的纹状体和大脑皮层中可观察到选择性和进行性的神经元丧失。我们研究了除纹状体和皮层外,多聚谷氨酰胺扩增聚集体是否出现在大脑的其他区域,以及多聚谷氨酰胺扩增聚集体的形成与转录失调之间是否存在关联。我们构建了表达与增强型绿色荧光蛋白(EGFP)融合的突变型截短N端亨廷顿蛋白(多聚谷氨酰胺扩增)的转基因小鼠品系,并使用从大脑提取的mRNA进行了高密度寡核苷酸阵列分析,随后进行了TaqMan RT-PCR和原位杂交。转基因小鼠形成了多聚谷氨酰胺-EGFP荧光聚集体,该系统使我们无需进行免疫组织化学研究就能直接观察到大脑各个区域的多聚谷氨酰胺扩增聚集体。我们在此表明,多聚谷氨酰胺-EGFP聚集体在下丘脑中强烈表达,在转基因小鼠大脑中,催产素、加压素和可卡因-安非他明调节转录物等六种下丘脑神经肽mRNA的表达下调,而下丘脑神经元未出现明显丧失。这些结果表明,下丘脑在这些小鼠中易形成聚集体,这可能导致该脑区特定基因的下调。

相似文献

1
Decreased expression of hypothalamic neuropeptides in Huntington disease transgenic mice with expanded polyglutamine-EGFP fluorescent aggregates.在具有扩展的聚谷氨酰胺-EGFP荧光聚集体的亨廷顿病转基因小鼠中,下丘脑神经肽表达降低。
J Neurochem. 2005 May;93(3):641-53. doi: 10.1111/j.1471-4159.2005.03035.x.
2
RNA-binding protein TLS is a major nuclear aggregate-interacting protein in huntingtin exon 1 with expanded polyglutamine-expressing cells.RNA结合蛋白TLS是亨廷顿蛋白外显子1中与表达多聚谷氨酰胺扩增的细胞内主要核聚集体相互作用的蛋白。
J Biol Chem. 2008 Mar 7;283(10):6489-500. doi: 10.1074/jbc.M705306200. Epub 2007 Dec 31.
3
Proteomics of polyglutamine aggregates.聚谷氨酰胺聚集体的蛋白质组学
Methods Enzymol. 2006;412:63-76. doi: 10.1016/S0076-6879(06)12005-4.
4
14-3-3zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein.14-3-3ζ蛋白对于多聚谷氨酰胺扩展的亨廷顿蛋白的聚集体形成是不可或缺的。
Neurosci Lett. 2008 Jan 24;431(1):45-50. doi: 10.1016/j.neulet.2007.11.018. Epub 2007 Nov 17.
5
Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.表达突变全长亨廷顿舞蹈病(HD)互补DNA的转基因小鼠:亨廷顿舞蹈病运动变化和选择性神经元丢失的范例
Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1035-45. doi: 10.1098/rstb.1999.0456.
6
A structure-based analysis of huntingtin mutant polyglutamine aggregation and toxicity: evidence for a compact beta-sheet structure.基于结构的亨廷顿蛋白突变体多聚谷氨酰胺聚集与毒性分析:致密β-折叠结构的证据
Hum Mol Genet. 2005 Mar 15;14(6):765-74. doi: 10.1093/hmg/ddi071. Epub 2005 Feb 2.
7
Modulating huntingtin half-life alters polyglutamine-dependent aggregate formation and cell toxicity.调节亨廷顿蛋白的半衰期可改变多聚谷氨酰胺依赖性聚集体的形成及细胞毒性。
J Neurochem. 2004 May;89(4):962-73. doi: 10.1111/j.1471-4159.2004.02376.x.
8
Disease progression despite early loss of polyglutamine protein expression in SCA7 mouse model.尽管SCA7小鼠模型中聚谷氨酰胺蛋白表达早期丧失,但疾病仍在进展。
J Neurosci. 2004 Feb 25;24(8):1881-7. doi: 10.1523/JNEUROSCI.4407-03.2004.
9
Human cytomegalovirus UL97 kinase prevents the deposition of mutant protein aggregates in cellular models of Huntington's disease and ataxia.人类巨细胞病毒 UL97 激酶可防止亨廷顿病和共济失调的细胞模型中突变蛋白聚集体的沉积。
Neurobiol Dis. 2011 Jan;41(1):11-22. doi: 10.1016/j.nbd.2010.08.013. Epub 2010 Aug 20.
10
Significantly differential diffusion of neuropathological aggregates in the brain of transgenic mice carrying N-terminal mutant huntingtin fused with green fluorescent protein.携带与绿色荧光蛋白融合的 N 端突变 huntingtin 的转基因小鼠脑中神经病理聚集物的显著差异扩散。
Brain Struct Funct. 2013 Jan;218(1):283-94. doi: 10.1007/s00429-012-0401-x. Epub 2012 Mar 16.

引用本文的文献

1
From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington's Disease Research.从发病机制到治疗:亨廷顿病研究 150 年回顾。
Int J Mol Sci. 2023 Aug 21;24(16):13021. doi: 10.3390/ijms241613021.
2
Transition metal ions and neurotransmitters: coordination chemistry and implications for neurodegeneration.过渡金属离子与神经递质:配位化学及其对神经退行性变的影响
RSC Chem Biol. 2023 Jun 27;4(8):548-563. doi: 10.1039/d3cb00052d. eCollection 2023 Aug 3.
3
Microarray profiling of hypothalamic gene expression changes in Huntington's disease mouse models.
亨廷顿舞蹈病小鼠模型下丘脑基因表达变化的微阵列分析
Front Neurosci. 2022 Nov 3;16:1027269. doi: 10.3389/fnins.2022.1027269. eCollection 2022.
4
Oxytocin in Huntington's disease and the spectrum of amyotrophic lateral sclerosis-frontotemporal dementia.亨廷顿舞蹈症及肌萎缩侧索硬化症-额颞叶痴呆谱系中的催产素
Front Mol Neurosci. 2022 Sep 14;15:984317. doi: 10.3389/fnmol.2022.984317. eCollection 2022.
5
The Common Cellular Events in the Neurodegenerative Diseases and the Associated Role of Endoplasmic Reticulum Stress.神经退行性疾病中的常见细胞事件及内质网应激的相关作用。
Int J Mol Sci. 2022 May 24;23(11):5894. doi: 10.3390/ijms23115894.
6
Hornerin deposits in neuronal intranuclear inclusion disease: direct identification of proteins with compositionally biased regions in inclusions.神经元核内包涵体病中的 Hornerin 沉积:通过组成性偏倚区域在包涵体中直接鉴定蛋白质。
Acta Neuropathol Commun. 2022 Mar 4;10(1):28. doi: 10.1186/s40478-022-01333-8.
7
Effects of excitotoxicity in the hypothalamus in transgenic mouse models of Huntington disease.亨廷顿病转基因小鼠模型中下丘脑兴奋性毒性的作用
Heliyon. 2021 Aug 14;7(8):e07808. doi: 10.1016/j.heliyon.2021.e07808. eCollection 2021 Aug.
8
Oxytocin Prevents the Development of 3-NP-Induced Anxiety and Depression in Male and Female Rats: Possible Interaction of OXTR and mGluR2.催产素可预防雄性和雌性大鼠中 3-NP 诱导的焦虑和抑郁的发展:OXTR 和 mGluR2 的可能相互作用。
Cell Mol Neurobiol. 2022 May;42(4):1105-1123. doi: 10.1007/s10571-020-01003-0. Epub 2020 Nov 17.
9
FACS-array-based cell purification yields a specific transcriptome of striatal medium spiny neurons in a murine Huntington disease model.基于 FACS 阵列的细胞纯化可在小鼠亨廷顿病模型中获得纹状体中型棘突神经元的特定转录组。
J Biol Chem. 2020 Jul 17;295(29):9768-9785. doi: 10.1074/jbc.RA120.012983. Epub 2020 Jun 4.
10
The Role of Hypothalamic Pathology for Non-Motor Features of Huntington's Disease.下丘脑病理学在亨廷顿舞蹈病非运动特征中的作用
J Huntingtons Dis. 2019;8(4):375-391. doi: 10.3233/JHD-190372.